What happened
Tata Consultancy Services launched a new AI agent platform focused on drug development. The tool helps life sciences teams automate research tasks and organize biological data. TCS aims to reduce the time needed to bring new medical treatments to market.
The context
IT services providers are moving from generic chatbots to industry-specific AI agents. TCS is targeting pharma research, an area where automated tools can quickly analyze complex lab data.
Sources
- Business Standard ↗ via Google News Reported